LMW heparins: from transition to fruition.
Check
W
W
D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy; D003362:Cost-Benefit Analysis; D017984:Enoxaparin / Q000191:economics / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D014481:United States; D020246:Venous Thrombosis / Q000188:drug therapy
D000925:Anticoagulants; D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight